Researchers at the University of Oklahoma have discovered that cigarette smoke triggers a previously unrecognized immune system pathway that accelerates cardiovascular disease. According to findings published in Circulation Research, smoke exposure causes neutrophils—the most abundant white blood cells in the body—to become overactive, creating chronic inflammation that leads to arterial plaque buildup and potential heart attacks or strokes.
How Does Smoking Damage Arteries?
The study, conducted using a mouse model of atherosclerosis, reveals that cigarette smoke acts as a direct agitator to neutrophils. Once these “first responder” immune cells detect chemicals from cigarette smoke, they increase rapidly in number and migrate into blood vessels. Dr. Prabhakara Nagareddy, a professor of medicine at the OU College of Medicine and the paper’s senior author, explains that smoking essentially “reprograms” these cells. Instead of protecting the body, these neutrophils become overactive and interact with macrophages—another white blood cell type—leading to their death.
When these neutrophils die, they release proteins known as Interleukin 1-alpha and Interleukin-1 beta. This process cripples the macrophages, which are responsible for clearing out bad cholesterol and dead cells. When macrophages fail, arteries become vulnerable to plaque dislodging, which can result in clots, heart attacks, or strokes.
Neutrophils are the most abundant white blood cell in the body. Their primary role is to find and vanquish invading pathogens, but researchers found that smoke exposure turns this defensive mechanism against the body’s own cardiovascular system.
Does Inhaling Matter for Cardiovascular Risk?
A surprising finding from the research suggests that the cardiovascular damage caused by tobacco is not limited to the lungs. The study showed that chemicals in cigarette smoke triggered these inflammatory effects even when administered orally. Dr. Nagareddy notes that this indicates tobacco-related chemicals can activate immune cells after being absorbed into the body, suggesting the cardiovascular impact may extend beyond inflammation that begins in the lungs.
What Are the Future Implications for Heart Disease Treatment?
Current cardiovascular therapies largely focus on lowering cholesterol levels, but researchers argue that inflammation is the other half of the story. By identifying the specific immune pathway involved in smoking-related damage, the University of Oklahoma team hopes to develop new treatments that target chronic inflammation directly.
The research team, led by Dr. Nagareddy and postdoctoral researcher Dr. Dipanjan Chattopadhyay, plans to expand their work in several directions:
- Chemical Identification: Since cigarette smoke contains over 7,000 chemical compounds, the team aims to isolate which specific chemicals drive this harmful inflammatory response.
- Alternative Delivery Systems: Future studies will investigate whether nicotine pouches and vaping products trigger similar neutrophil reactions.
- Human Clinical Studies: The researchers intend to move from mouse models to human subjects to confirm these findings in a clinical setting.
While medical science continues to uncover the biological mechanisms behind heart disease, the most effective way to reduce cardiovascular risk remains avoiding tobacco products or quitting smoking entirely, according to the researchers.
Frequently Asked Questions
What is the link between smoking and heart attacks?
According to the study, smoking triggers an immune response that causes neutrophils to release proteins that disable macrophages. This prevents the body from clearing bad cholesterol, leading to arterial plaque that can dislodge and cause a heart attack.
Do these findings apply to vaping?
The researchers plan to study vaping and nicotine pouches in future experiments to determine if these delivery systems trigger the same inflammatory immune response as traditional cigarettes.
Is the damage limited to the lungs?
No. The research suggests that tobacco chemicals can activate immune cells after being absorbed into the body, meaning the inflammatory damage may extend beyond inflammation that begins in the lungs.
Are you interested in the latest developments in cardiovascular health? Subscribe to our newsletter for updates on this research and other breakthroughs in medical science.
Keep reading
